ECSP034853A - PHARMACEUTICAL COMPOSITION LIQUID - Google Patents
PHARMACEUTICAL COMPOSITION LIQUIDInfo
- Publication number
- ECSP034853A ECSP034853A ECSP034853A ECSP034853A EC SP034853 A ECSP034853 A EC SP034853A EC SP034853 A ECSP034853 A EC SP034853A EC SP034853 A ECSP034853 A EC SP034853A
- Authority
- EC
- Ecuador
- Prior art keywords
- pain
- pharmaceutical composition
- component
- disorders
- compositions
- Prior art date
Links
- 239000007788 liquid Substances 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical class NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- HMJIYCCIJYRONP-UHFFFAOYSA-N (+-)-Isradipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1C1=CC=CC2=NON=C12 HMJIYCCIJYRONP-UHFFFAOYSA-N 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000020925 Bipolar disease Diseases 0.000 abstract 1
- 206010006002 Bone pain Diseases 0.000 abstract 1
- 208000014644 Brain disease Diseases 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 206010019196 Head injury Diseases 0.000 abstract 1
- 208000006083 Hypokinesia Diseases 0.000 abstract 1
- 206010021639 Incontinence Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 206010026749 Mania Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000000112 Myalgia Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 206010038419 Renal colic Diseases 0.000 abstract 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 230000003483 hypokinetic effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 206010022437 insomnia Diseases 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 208000013465 muscle pain Diseases 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 150000005846 sugar alcohols Polymers 0.000 abstract 1
- 206010042772 syncope Diseases 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describe una composición farmacéutica líquida de un análogo de GABA que comprende al menos un alcohol polihidroxílico que contiene de 2 a 6 átomos de carbono, que tiene un pH desde aproximadamente 5,5 a aproximadamente 7, 0, y además una composición farmacéutica líquida en dos componentes que comprende un primer componente que comprende una mezcla de polvo que comprende un análogo de GABA y un alcohol polihidroxílico sólido, y un segundo componente que comprende una base líquida, así como métodos para preparar las composiciones y un método para tratar enfermedades cerebrales, incluyendo epilepsia, ataques de desfallecimiento, hipoquinesia y traumatismos craneales, trastornos neurodegenerativos, depresión, manía y trastornos bipolares, ansiedad, pánico, inflamación, cólico renal, insomnio, trastornos gastrointestinales, incontinencia, dolor, incluyendo dolor neuropático, dolor muscular, dolor esquelético y migraña, utilizando una cantidad terapéuticamente eficaz de las composiciones farmacéuticasA liquid pharmaceutical composition of a GABA analog comprising at least one polyhydric alcohol containing from 2 to 6 carbon atoms is described, having a pH from about 5.5 to about 7.0, and also a liquid pharmaceutical composition in two components comprising a first component comprising a powder mixture comprising a GABA analogue and a solid polyhydroxy alcohol, and a second component comprising a liquid base, as well as methods for preparing the compositions and a method for treating brain diseases, including epilepsy, fainting attacks, hypokinesia and head injuries, neurodegenerative disorders, depression, mania and bipolar disorders, anxiety, panic, inflammation, renal colic, insomnia, gastrointestinal disorders, incontinence, pain, including neuropathic pain, muscle pain, skeletal pain and migraine, using a therapeutically effective amount icaz of pharmaceutical compositions
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29383201P | 2001-05-25 | 2001-05-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP034853A true ECSP034853A (en) | 2003-12-24 |
Family
ID=34699738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP034853 ECSP034853A (en) | 2001-05-25 | 2003-11-17 | PHARMACEUTICAL COMPOSITION LIQUID |
Country Status (5)
| Country | Link |
|---|---|
| EC (1) | ECSP034853A (en) |
| GT (1) | GT200200089A (en) |
| PY (1) | PY0211943A (en) |
| TN (1) | TNSN03125A1 (en) |
| UA (1) | UA75138C2 (en) |
-
2002
- 2002-04-29 UA UA20031110602A patent/UA75138C2/en unknown
- 2002-05-20 GT GT200200089A patent/GT200200089A/en unknown
- 2002-05-22 PY PY200200211943A patent/PY0211943A/en unknown
-
2003
- 2003-07-08 TN TNPCT/IB2002/001500A patent/TNSN03125A1/en unknown
- 2003-11-17 EC ECSP034853 patent/ECSP034853A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PY0211943A (en) | 2004-07-01 |
| GT200200089A (en) | 2003-05-15 |
| TNSN03125A1 (en) | 2005-12-23 |
| UA75138C2 (en) | 2006-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2002000403A (en) | LIQUID PHARMACEUTICAL COMPOSITION | |
| ATE206305T1 (en) | METHODS FOR TREATING MIND OR MENTAL DISEASES AND MIND OR MENTAL DISEASES ACCOMPANIED BY SEIZURES | |
| UA49011C2 (en) | Derivatives of cyclic amino acid, pharmaceutical composition and method of treatment | |
| EA199800682A1 (en) | DERIVATIVES OF CYCLIC AMINO ACID OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF DEPRESSION, STATE OF PANIC, FEAR AND PAIN PATIENTS | |
| EA200300854A1 (en) | APPLICATION OF REVERSE AGONISTS OF THE GUMKA IN COMBINATION WITH PARTIAL AGONISTS OF NICOTINE RECEPTORS, ESTROGEN, ELECTORAL MODULATORS OF ESTROGEN OR VITAMIN E FOR TREATMENT OF COGNITIVE RADIATION. | |
| PL347469A1 (en) | Use of certain drugs for treating nerve root injury | |
| WO2005063297A3 (en) | Melatonin combination therapy for improving sleep quality | |
| RU2004110041A (en) | PHARMACEUTICAL COMPOSITION CONTAINING GABAPENTIN OR ITS ANALOGU AND ALPHA-AMINOAMID, AND ITS APPLICATION AS ANALGETIC | |
| ATE353645T1 (en) | USE OF 2-OXO-1-PYRROLIDINE DERIVATIVES FOR PRODUCING A MEDICINAL PRODUCT FOR THE TREATMENT OF DYSKINESIA | |
| SE9501567D0 (en) | A new combination | |
| ATE277608T1 (en) | 2-ARACHIDONYL GLYCEROL, AN INHIBITOR OF TUMOR NECROSIS FACTOR -ALFA AND BRAIN NEUROPROTECTOR IN CLOSED HEAD INJURIES | |
| US20160128933A1 (en) | Therapeutic Methods and Compositions | |
| WO2006002096A3 (en) | Low doses of l-citrulline for treating diseases | |
| BR9912581A (en) | Processes to treat or prevent a disorder caused by dysfunction of gastrointestinal motility in a human and to elicit a prokinetic effect in a human, and pharmaceutical composition | |
| IL120006A0 (en) | Valnoctamide stereoisomers a method for their separation and uses thereof | |
| ATE289583T1 (en) | STEREOISOMERS OF PROPYL-ISOPROPYLACETAMIDE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME | |
| KR920701122A (en) | New Bicyclic Amino-Substituted Compounds | |
| PY0211943A (en) | LIQUID PHARMACEUTICAL COMPOSITION | |
| CN1281222C (en) | Drug composition for preventing and treating prospermia and/or sexual excitation hypersensitivity | |
| UY27310A1 (en) | PHARMACEUTICAL COMPOSITION LIQUID | |
| DE602006009848D1 (en) | THE REGENERATION OF NEURONS OF THE CENTRAL NERVOUS SYSTEM STIMULATING PEPTIDE SUBSTANCE, PHARMACEUTICAL COMPOSITION BASED THEREFROM, AND METHOD OF THEIR APPLICATION | |
| BRPI0417797A (en) | biologically active blood serum, methods for producing it and its uses | |
| KR20050003599A (en) | a fragrance composition and wet tissue with that | |
| JP2022510363A (en) | A synergistic composition comprising (R) -2- (2-oxopyrrolidine-1-yl) butaneamide and (S) -2- (2-oxopyrrolidine-1-yl) butaneamide in a non-racemic ratio. | |
| RU2203660C1 (en) | Nootropic agent "nootobril" in capsule form |